30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Otonomy Inc (OTIC)

Track

Stock chart
Ticker: OTIC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
CAPPS VICKIE L
1 sale — total 4,342 USD
Sale 28 Nov 2022
Value US$1,977,460.73 | Price 365.06 | Shares 25,548
Sale 28 Mar 2022
Value US$1,529,154.06 | Price 284.28 | Shares 67,110
Sale 28 Mar 2022
Value US$13,570.71 | Price 2.41 | Shares 5,624
Sale 28 Mar 2022
Value US$8,023.22 | Price 2.41 | Shares 3,325
Sale 28 Mar 2022
Value US$27,129.36 | Price 2.41 | Shares 11,243
Sale 25 Mar 2022
Value US$4,362.88 | Price 2.39 | Shares 1,827
Sale 25 Mar 2022
Value US$9,587.82 | Price 2.39 | Shares 4,015
Sale 25 Mar 2022
Value US$5,669.11 | Price 2.39 | Shares 2,374
Sale 25 Mar 2022
Value US$19,166.09 | Price 2.39 | Shares 8,026
Sale 3 Mar 2021
Value US$307,396.63 | Price 2.70 | Shares 113,935
Sale 3 Mar 2021
Value US$559,147.01 | Price 2.70 | Shares 207,245
Sale 2 Mar 2021
Value US$400,638.90 | Price 2.90 | Shares 138,199
Sale 2 Mar 2021
Value US$728,736.12 | Price 2.90 | Shares 251,375
Sale 1 Mar 2021
Value US$175,983.86 | Price 2.86 | Shares 61,619
Sale 1 Mar 2021
Value US$320,103.34 | Price 2.86 | Shares 112,081
Sale 26 Feb 2021
Value US$331,851.46 | Price 2.83 | Shares 117,262
Sale 26 Feb 2021
Value US$603,616.36 | Price 2.83 | Shares 213,292
Sale 25 Feb 2021
Value US$326,006.39 | Price 2.95 | Shares 110,361
Sale 25 Feb 2021
Value US$592,983.01 | Price 2.95 | Shares 200,739
Sale 24 Feb 2021
Value US$532,239.29 | Price 2.98 | Shares 178,484
Sale 24 Feb 2021
Value US$968,109.28 | Price 2.98 | Shares 324,651
Sale 23 Feb 2021
Value US$274,686.34 | Price 2.89 | Shares 95,113
Sale 23 Feb 2021
Value US$499,638.44 | Price 2.89 | Shares 173,005
Planned sale 26 Jun 2017
Value US$22,612.50 | Price 18.75 | Shares 1,206
Planned sale 23 Jun 2017
Value US$42,846.00 | Price 18.50 | Shares 2,316
Planned sale 21 Nov 2016
Value US$26,302.64 | Price 18.07 | Shares 1,456
Planned sale 18 Nov 2016
Value US$165,703.08 | Price 18.07 | Shares 9,169
Planned sale 6 Sep 2016
Value US$95,206.80 | Price 17.95 | Shares 5,304
Planned sale 6 Sep 2016
Value US$68,443.35 | Price 17.95 | Shares 3,813
Planned sale 6 Sep 2016
Value US$217,787.35 | Price 17.95 | Shares 12,133
Planned sale 21 Dec 2015
Value US$228,753.45 | Price 28.38 | Shares 8,061
Planned sale 21 Dec 2015
Value US$367,073.61 | Price 27.83 | Shares 13,189
Planned sale 17 Dec 2015
Value US$9,055.50 | Price 30.19 | Shares 300
Planned sale 17 Dec 2015
Value US$80,045.28 | Price 29.65 | Shares 2,700
Planned sale 15 Dec 2015
Value US$141,916.96 | Price 27.25 | Shares 5,208
Sale 14 Dec 2015
Value US$2,770.24 | Price 27.70 | Shares 100
Sale 14 Dec 2015
Value US$35,135.69 | Price 27.26 | Shares 1,289
Sale 14 Dec 2015
Value US$33,706.32 | Price 26.15 | Shares 1,289
Planned sale 14 Dec 2015
Value US$58,363.47 | Price 25.14 | Shares 2,322
Sale 30 Nov 2015
Value US$17,239.80 | Price 29.22 | Shares 590
Sale 30 Nov 2015
Value US$77,786.24 | Price 28.64 | Shares 2,716
Sale 30 Nov 2015
Value US$17,239.80 | Price 29.22 | Shares 590
Sale 30 Nov 2015
Value US$77,786.24 | Price 28.64 | Shares 2,716
Sale 27 Nov 2015
Value US$840,130.00 | Price 28.97 | Shares 29,000
Sale 27 Nov 2015
Value US$840,130.00 | Price 28.97 | Shares 29,000
Sale 25 Nov 2015
Value US$1,006,068.00 | Price 28.91 | Shares 34,800
Sale 25 Nov 2015
Value US$1,006,068.00 | Price 28.91 | Shares 34,800
Sale 24 Nov 2015
Value US$1,037,875.00 | Price 28.75 | Shares 36,100
Sale 24 Nov 2015
Value US$1,037,875.00 | Price 28.75 | Shares 36,100
Sale 23 Nov 2015
Value US$2,298,760.00 | Price 28.45 | Shares 80,800
Sale 23 Nov 2015
Value US$2,298,760.00 | Price 28.45 | Shares 80,800
Sale 20 Nov 2015
Value US$2,398,701.00 | Price 28.59 | Shares 83,900
Sale 20 Nov 2015
Value US$2,398,701.00 | Price 28.59 | Shares 83,900
Sale 19 Nov 2015
Value US$3,640,780.00 | Price 28.60 | Shares 127,300
Sale 19 Nov 2015
Value US$3,640,780.00 | Price 28.60 | Shares 127,300
Sale 17 Nov 2015
Value US$5,818.00 | Price 29.09 | Shares 200
Sale 17 Nov 2015
Value US$313,862.40 | Price 28.80 | Shares 10,898
Sale 17 Nov 2015
Value US$5,818.00 | Price 29.09 | Shares 200
Sale 17 Nov 2015
Value US$313,862.40 | Price 28.80 | Shares 10,898
Planned sale 17 Nov 2015
Value US$86,057.40 | Price 28.69 | Shares 3,000
Sale 16 Nov 2015
Value US$2,925.00 | Price 29.25 | Shares 100
Planned sale 16 Nov 2015
Value US$145,887.03 | Price 28.56 | Shares 5,108
Planned sale 13 Nov 2015
Value US$322,375.20 | Price 30.95 | Shares 10,416
Planned sale 11 Nov 2015
Value US$74,850.00 | Price 24.95 | Shares 3,000
Planned sale 11 Nov 2015
Value US$129,939.60 | Price 24.95 | Shares 5,208
Planned sale 21 Sep 2015
Value US$517,575.62 | Price 24.36 | Shares 21,250
Planned sale 17 Sep 2015
Value US$74,850.00 | Price 24.95 | Shares 3,000
Planned sale 15 Sep 2015
Value US$130,139.20 | Price 24.95 | Shares 5,216
Planned sale 14 Sep 2015
Value US$119,896.50 | Price 23.98 | Shares 5,000
Planned sale 15 Jun 2015
Value US$593,285.00 | Price 23.73 | Shares 25,000
Buy 22 May 2015
Value US$38,960.48 | Price 24.35 | Shares 1,600
Buy 22 May 2015
Value US$82,807.68 | Price 24.36 | Shares 3,400
Buy 19 Aug 2014
Value US$243,135.38 | Price 15.50 | Shares 15,690
Buy 18 Aug 2014
Value US$2,750,000.00 | Price 16.00 | Shares 171,875
Buy 18 Aug 2014
Value US$1,750,000.00 | Price 16.00 | Shares 109,375
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-29 2022-11-28 S Sale
2.1
CAPPS VICKIE L
Non-Executive Director
25,548 -44.2%
365.06
US$1,977,461 		25,548 -44.2% 365.06 US$1,977,461
2022-03-29 2022-03-28 S Sale
Foster Alan Charles

Chief Scientific Officer

Officer
67,110 +19.5%
284.28
US$1,529,154 		67,110 +19.5% 284.28 US$1,529,154
2022-03-29 2022-03-28 S Sale
Cayer Paul E

Ch. Financial & Business Offcr

Officer
51,193 -39.1%
267.89
US$3,696,211 		51,193 -39.1% 267.89 US$3,696,211
2022-03-29 2022-03-28 S Sale
Savel Robert Michael II

Chief Technical Officer

Officer
3,325 -2.2%
2.41
US$8,023 		3,325 -2.2% 2.41 US$8,023
2022-03-29 2022-03-28 S Sale
Weber David Allen

President & CEO

Executive Director
11,243 -2.9%
2.41
US$27,129 		11,243 -2.9% 2.41 US$27,129
2022-03-29 2022-03-25 S Sale
Foster Alan Charles

Chief Scientific Officer

Officer
1,827 -1.0%
2.39
US$4,363 		1,827 -1.0% 2.39 US$4,363
2022-03-29 2022-03-25 S Sale
Cayer Paul E

Ch. Financial & Business Offcr

Officer
4,015 -1.7%
2.39
US$9,588 		4,015 -1.7% 2.39 US$9,588
2022-03-29 2022-03-25 S Sale
Savel Robert Michael II

Chief Technical Officer

Officer
2,374 -1.6%
2.39
US$5,669 		2,374 -1.6% 2.39 US$5,669
2022-03-29 2022-03-25 S Sale
Weber David Allen

President & CEO

Executive Director
8,026 -2.0%
2.39
US$19,166 		8,026 -2.0% 2.39 US$19,166
2021-03-03 2021-03-03 S Sale
4.0
Lichter Jay
Non-Executive Director
113,935 -100.0%
2.70
US$307,397 		113,935 -100.0% 2.70 US$307,397
2021-03-03 2021-03-03 S Sale
4.0
Lichter Jay
Non-Executive Director
207,245 -100.0%
2.70
US$559,147 		207,245 -100.0% 2.70 US$559,147
2021-03-02 2021-03-02 S Sale
4.0
Lichter Jay
Non-Executive Director
138,199 -54.8%
2.90
US$400,639 		138,199 -54.8% 2.90 US$400,639
2021-03-02 2021-03-02 S Sale
4.0
Lichter Jay
Non-Executive Director
251,375 -54.8%
2.90
US$728,736 		251,375 -54.8% 2.90 US$728,736
2021-03-02 2021-03-01 S Sale
4.0
Lichter Jay
Non-Executive Director
61,619 -19.6%
2.86
US$175,984 		61,619 -19.6% 2.86 US$175,984
2021-03-02 2021-03-01 S Sale
4.0
Lichter Jay
Non-Executive Director
112,081 -19.6%
2.86
US$320,103 		112,081 -19.6% 2.86 US$320,103
2021-03-02 2021-02-26 S Sale
4.0
Lichter Jay
Non-Executive Director
117,262 -27.2%
2.83
US$331,851 		117,262 -27.2% 2.83 US$331,851
2021-03-02 2021-02-26 S Sale
4.0
Lichter Jay
Non-Executive Director
213,292 -27.2%
2.83
US$603,616 		213,292 -27.2% 2.83 US$603,616
2021-02-25 2021-02-25 S Sale
4.0
Lichter Jay
Non-Executive Director
110,361 -20.4%
2.95
US$326,006 		110,361 -20.4% 2.95 US$326,006
2021-02-25 2021-02-25 S Sale
4.0
Lichter Jay
Non-Executive Director
200,739 -20.4%
2.95
US$592,983 		200,739 -20.4% 2.95 US$592,983
2021-02-25 2021-02-24 S Sale
4.0
Lichter Jay
Non-Executive Director
178,484 -24.8%
2.98
US$532,239 		178,484 -24.8% 2.98 US$532,239
2021-02-25 2021-02-24 S Sale
4.0
Lichter Jay
Non-Executive Director
324,651 -24.8%
2.98
US$968,109 		324,651 -24.8% 2.98 US$968,109
2021-02-25 2021-02-23 S Sale
4.0
Lichter Jay
Non-Executive Director
95,113 -11.7%
2.89
US$274,686 		95,113 -11.7% 2.89 US$274,686
2021-02-25 2021-02-23 S Sale
4.0
Lichter Jay
Non-Executive Director
173,005 -11.7%
2.89
US$499,638 		173,005 -11.7% 2.89 US$499,638
2017-06-27 2017-06-26 PlS Planned sale LOUMEAU ERIC J

GC & Chief Compliance Officer
1,206 -100.0%
18.75
US$22,612 		1,206 -100.0% 18.75 US$22,612
2017-06-27 2017-06-23 PlS Planned sale LOUMEAU ERIC J

GC & Chief Compliance Officer
2,316 -65.8%
18.50
US$42,846 		2,316 -65.8% 18.50 US$42,846
2016-11-22 2016-11-21 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
1,456 -13.3%
18.07
US$26,303 		1,456 -13.3% 18.07 US$26,303
2016-11-22 2016-11-18 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
9,169 -49.2%
18.07
US$165,703 		9,169 -49.2% 18.07 US$165,703
2016-09-08 2016-09-06 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
5,304 -35.9%
17.95
US$95,207 		5,304 -35.9% 17.95 US$95,207
2016-09-08 2016-09-06 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
3,813 -20.5%
17.95
US$68,443 		3,813 -20.5% 17.95 US$68,443
2016-09-08 2016-09-06 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
12,133 -39.5%
17.95
US$217,787 		12,133 -39.5% 17.95 US$217,787
2015-12-22 2015-12-21 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
8,061 -47.5%
28.38
US$228,753 		8,061 -47.5% 28.38 US$228,753
2015-12-22 2015-12-21 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
13,189 -43.7%
27.83
US$367,074 		13,189 -43.7% 27.83 US$367,074
2015-12-18 2015-12-17 PlS Planned sale Cayer Paul E

Ch. Financial & Business Offcr

Officer
300 -3.0%
30.19
US$9,056 		300 -3.0% 30.19 US$9,056
2015-12-18 2015-12-17 PlS Planned sale Cayer Paul E

Ch. Financial & Business Offcr

Officer
2,700 -21.4%
29.65
US$80,045 		2,700 -21.4% 29.65 US$80,045
2015-12-16 2015-12-15 PlS Planned sale Weber David Allen

President & CEO

Executive Director
5,208 -22.8%
27.25
US$141,917 		5,208 -22.8% 27.25 US$141,917
2015-12-16 2015-12-14 S Sale Savel Robert Michael II

Chief Technical Officer

Officer
100 -7.4%
27.70
US$2,770 		100 -7.4% 27.70 US$2,770
2015-12-16 2015-12-14 S Sale Savel Robert Michael II

Chief Technical Officer

Officer
1,289 -48.7%
27.26
US$35,136 		1,289 -48.7% 27.26 US$35,136
2015-12-16 2015-12-14 S Sale Savel Robert Michael II

Chief Technical Officer

Officer
1,289 -32.8%
26.15
US$33,706 		1,289 -32.8% 26.15 US$33,706
2015-12-16 2015-12-14 PlS Planned sale Savel Robert Michael II

Chief Technical Officer

Officer
2,322 -37.1%
25.14
US$58,363 		2,322 -37.1% 25.14 US$58,363
2015-11-30 2015-11-30 S Sale ORBIMED ADVISORS LLC Non-Executive Director
590 -0.0%
29.22
US$17,240 		590 -0.0% 29.22 US$17,240
2015-11-30 2015-11-30 S Sale ORBIMED ADVISORS LLC Non-Executive Director
2,716 -0.1%
28.64
US$77,786 		2,716 -0.1% 28.64 US$77,786
2015-11-30 2015-11-30 S Sale Khuong Chau Quang Non-Executive Director
590 -0.0%
29.22
US$17,240 		590 -0.0% 29.22 US$17,240
2015-11-30 2015-11-30 S Sale Khuong Chau Quang Non-Executive Director
2,716 -0.1%
28.64
US$77,786 		2,716 -0.1% 28.64 US$77,786
2015-11-30 2015-11-27 S Sale ORBIMED ADVISORS LLC Non-Executive Director
29,000 -1.5%
28.97
US$840,130 		29,000 -1.5% 28.97 US$840,130
2015-11-30 2015-11-27 S Sale Khuong Chau Quang Non-Executive Director
29,000 -1.5%
28.97
US$840,130 		29,000 -1.5% 28.97 US$840,130
2015-11-30 2015-11-25 S Sale ORBIMED ADVISORS LLC Non-Executive Director
34,800 -1.8%
28.91
US$1,006,068 		34,800 -1.8% 28.91 US$1,006,068
2015-11-30 2015-11-25 S Sale Khuong Chau Quang Non-Executive Director
34,800 -1.8%
28.91
US$1,006,068 		34,800 -1.8% 28.91 US$1,006,068
2015-11-24 2015-11-24 S Sale Khuong Chau Quang Non-Executive Director
36,100 -1.8%
28.75
US$1,037,875 		36,100 -1.8% 28.75 US$1,037,875
2015-11-24 2015-11-24 S Sale ORBIMED ADVISORS LLC Non-Executive Director
36,100 -1.8%
28.75
US$1,037,875 		36,100 -1.8% 28.75 US$1,037,875
2015-11-24 2015-11-23 S Sale Khuong Chau Quang Non-Executive Director
80,800 -4.0%
28.45
US$2,298,760 		80,800 -4.0% 28.45 US$2,298,760
2015-11-24 2015-11-23 S Sale ORBIMED ADVISORS LLC Non-Executive Director
80,800 -4.0%
28.45
US$2,298,760 		80,800 -4.0% 28.45 US$2,298,760
2015-11-24 2015-11-20 S Sale Khuong Chau Quang Non-Executive Director
83,900 -4.0%
28.59
US$2,398,701 		83,900 -4.0% 28.59 US$2,398,701
2015-11-24 2015-11-20 S Sale ORBIMED ADVISORS LLC Non-Executive Director
83,900 -4.0%
28.59
US$2,398,701 		83,900 -4.0% 28.59 US$2,398,701
2015-11-19 2015-11-19 S Sale ORBIMED ADVISORS LLC Non-Executive Director
127,300 -5.7%
28.60
US$3,640,780 		127,300 -5.7% 28.60 US$3,640,780
2015-11-19 2015-11-19 S Sale Khuong Chau Quang Non-Executive Director
127,300 -5.7%
28.60
US$3,640,780 		127,300 -5.7% 28.60 US$3,640,780
2015-11-19 2015-11-17 S Sale ORBIMED ADVISORS LLC Non-Executive Director
200 -0.0%
29.09
US$5,818 		200 -0.0% 29.09 US$5,818
2015-11-19 2015-11-17 S Sale Khuong Chau Quang Non-Executive Director
200 -0.0%
29.09
US$5,818 		200 -0.0% 29.09 US$5,818
2015-11-19 2015-11-17 S Sale ORBIMED ADVISORS LLC Non-Executive Director
10,898 -0.5%
28.80
US$313,862 		10,898 -0.5% 28.80 US$313,862
2015-11-19 2015-11-17 S Sale Khuong Chau Quang Non-Executive Director
10,898 -0.5%
28.80
US$313,862 		10,898 -0.5% 28.80 US$313,862
2015-11-17 2015-11-17 PlS Planned sale Cayer Paul E

Ch. Financial & Business Offcr

Officer
3,000 -23.8%
28.69
US$86,057 		3,000 -23.8% 28.69 US$86,057
2015-11-17 2015-11-16 S Sale Weber David Allen

President & CEO

Executive Director
100 -0.6%
29.25
US$2,925 		100 -0.6% 29.25 US$2,925
2015-11-17 2015-11-16 PlS Planned sale Weber David Allen

President & CEO

Executive Director
5,108 -22.4%
28.56
US$145,887 		5,108 -22.4% 28.56 US$145,887
2015-11-13 2015-11-13 PlS Planned sale Weber David Allen

President & CEO

Executive Director
10,416 -95.1%
30.95
US$322,375 		10,416 -95.1% 30.95 US$322,375
2015-11-12 2015-11-11 PlS Planned sale Cayer Paul E

CFO/Ch. Business Offcr & Sec.

Officer
3,000 -23.8%
24.95
US$74,850 		3,000 -23.8% 24.95 US$74,850
2015-11-12 2015-11-11 PlS Planned sale Weber David Allen

President & CEO

Executive Director
5,208 -90.6%
24.95
US$129,940 		5,208 -90.6% 24.95 US$129,940
2015-09-22 2015-09-21 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
21,250 -70.4%
24.36
US$517,576 		21,250 -70.4% 24.36 US$517,576
2015-09-18 2015-09-17 PlS Planned sale Cayer Paul E

CFO/Ch. Business Offcr & Sec.

Officer
3,000 -23.8%
24.95
US$74,850 		3,000 -23.8% 24.95 US$74,850
2015-09-16 2015-09-15 PlS Planned sale Weber David Allen

President & CEO

Executive Director
5,216 -90.6%
24.95
US$130,139 		5,216 -90.6% 24.95 US$130,139
2015-09-15 2015-09-14 PlS Planned sale Savel Robert Michael II

Chief Technical Officer

Officer
5,000 -79.9%
23.98
US$119,896 		5,000 -79.9% 23.98 US$119,896
2015-06-17 2015-06-15 PlS Planned sale Savel Robert Michael II

Chief Technical Officer

Officer
25,000 -95.2%
23.73
US$593,285 		25,000 -95.2% 23.73 US$593,285
2015-05-27 2015-05-22 B Purchase CAPPS VICKIE L Non-Executive Director
1,600 +inf%
24.35
US$38,960 		1,600 +inf% 24.35 US$38,960
2015-05-27 2015-05-22 B Purchase CAPPS VICKIE L Non-Executive Director
3,400 +inf%
24.36
US$82,808 		3,400 +inf% 24.36 US$82,808
2014-08-21 2014-08-19 B Purchase Novo A/S

SEE REMARKS

Large shareholder
15,690 +0.7%
15.50
US$243,135 		15,690 +0.7% 15.50 US$243,135
2014-08-19 2014-08-18 B Purchase Novo A/S

SEE REMARKS

Large shareholder
171,875 +8.6%
16.00
US$2,750,000 		171,875 +8.6% 16.00 US$2,750,000
2014-08-19 2014-08-18 B Purchase Avalon Ventures VIII LP Large shareholder
109,375 +15.5%
16.00
US$1,750,000 		109,375 +15.5% 16.00 US$1,750,000
Explore more

More insider trading research around Otonomy Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America